OpenAlex records 145 works, ~15,820 citations, and an h-index of 45 for Edward J. Oakeley (ORCID 0000-0001-6226-7470), while Semantic Scholar-style data reports an h-index of 44 with 14,666 citations over 93 papers β a discrepancy suggesting inconsistent author disambiguation, a known limitation of bibliometric databases. His citation trajectory peaked in 2003β2011 (e.g., 3,376 citations in 2004, 1,646 in 2011), then declined; a striking spike of 43 works in 2023 with only 11 citations suggests catalogued conference abstracts rather than primary research. His most-cited contributions are collaborative: flagellin perception in Arabidopsis (1,841 citations, Nature 2004), chromosome-wide DNA methylation mapping (1,783 citations, Nature Genetics 2005), and mouse methylome regulation (1,506 citations, Nature 2011) .
The two detailed papers show strong methodological breadth. The sFRP1 breast cancer study (Breast Cancer Research, 2009) reports in vitro (TOPFlash 2.7-fold reduction, 31% proliferation decrease) and in vivo xenograft effects (68% vs 20% tumor-free mice at day 39; 20-fold fewer lung metastases), with GEO data deposition (GSE13806) and explicit single-cell-line limitations . The 1998 collodion-film method paper is a practical techniques contribution with good reproducibility (8/10) but limited quantitative benchmarking .
Oakeley's profile reflects a core-facility/collaborative genomics expert (FMI, Novartis, Basel ecosystem) rather than a project lead: nearly all top papers position him as a middle author providing bioinformatics, transcriptomics, or methylation analysis. Blind spots include single-model studies (one breast cancer line; limited cell types in methods papers), declining primary-output post-2016, and heavy reliance on co-author prestige for citation metrics. Strengths: sustained methodological rigor, data deposition practices, and contributions to RNA-seq quality standards (SEQC, 1,098 citations) .
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.